Literature DB >> 10527830

Protection of MLV vector particles from human complement.

S Breun1, B Salmons, W H Günzburg, J G Baumann.   

Abstract

Murine cell-derived MLV vector particles usually are highly sensitive to human complement-mediated lysis. Expression of the human complement inhibitor CD59 on murine packaging cells resulted in partial protection of these cells from lysis caused by human complement proteins. Furthermore, CD59 was incorporated into MLV vector particles released by these packaging cells, leading to an improved resistance of the virions against human complement-mediated inactivation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527830     DOI: 10.1006/bbrc.1999.1474

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Immune Protection of Retroviral Vectors Upon Molecular Painting with the Complement Regulatory Protein CD59.

Authors:  Susanne Heider; Sandra Kleinberger; Feliks Kochan; John A Dangerfield; Christoph Metzner
Journal:  Mol Biotechnol       Date:  2016-07       Impact factor: 2.695

Review 2.  Postexit surface engineering of retroviral/lentiviral vectors.

Authors:  Christoph Metzner; Feliks Kochan; John A Dangerfield
Journal:  Biomed Res Int       Date:  2013-04-17       Impact factor: 3.411

3.  Fluorescence molecular painting of enveloped viruses.

Authors:  Christoph Metzner; Feliks Kochan; John A Dangerfield
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

Review 4.  Biomedical applications of glycosylphosphatidylinositol-anchored proteins.

Authors:  Susanne Heider; John A Dangerfield; Christoph Metzner
Journal:  J Lipid Res       Date:  2016-08-19       Impact factor: 5.922

Review 5.  Engineering targeted viral vectors for gene therapy.

Authors:  Reinhard Waehler; Stephen J Russell; David T Curiel
Journal:  Nat Rev Genet       Date:  2007-07-03       Impact factor: 53.242

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.